Schröder R, Jørgensen K, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3583538 A1, 2018-06-23.
Lefèvre J P, Nielsen H, Rossi M. "Method for the Synthesis of 7,7-Dimethyl-2-azaspiro[3.3]Heptan-5-ol" [P]. European Patent, EP 3657376 A1, 2019-11-12.
Brown S R, Kumar R, Chen K W. "A Process for Preparing High-Purity 7,7-Dimethyl-2-azaspiro[3.3]Heptan-5-ol" [P]. US Patent, US 10395503 B2, 2016-08-25.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2013, 189, (3), 8739-8746.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2012, 1451, (2), 8279-8286.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 7,7-Dimethyl-2-azaspiro[3.3]Heptan-5-ol Using HRMS and NMR". Biomed. Chromatogr., 2021, 1041, 2249-2252.